(HST) Host Hotels & Resorts - Ratings and Ratios
Luxury Hotels, Upper-Upscale Hotels, Rooms, Properties, Joint Ventures
EPS (Earnings per Share)
Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 25.1% |
| Value at Risk 5%th | 39.2% |
| Relative Tail Risk | -5.12% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.09 |
| Alpha | -10.04 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.442 |
| Beta | 1.055 |
| Beta Downside | 0.918 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.03% |
| Mean DD | 13.08% |
| Median DD | 13.52% |
Description: HST Host Hotels & Resorts October 30, 2025
Host Hotels & Resorts (NASDAQ:HST) is the largest lodging REIT in the S&P 500, owning 75 U.S. hotels and five international properties for roughly 42,900 rooms, plus non-controlling stakes in eight joint-venture hotels. The portfolio is anchored by premium brands such as Marriott, Ritz-Carlton, Hyatt, Hilton, Four Seasons and independent operators, reflecting a focus on luxury and upper-upscale assets.
Key recent metrics: FY 2023 adjusted funds-from-operations (AFFO) rose 12% YoY to $1.45 billion, driven by a rebound in occupancy to 73% and RevPAR growth of 9% amid a strong leisure travel surge. The REIT’s weighted-average lease term remains above 15 years, providing cash-flow stability, while its exposure to interest-rate risk is mitigated by a 2025-maturing $1.2 billion term loan at a fixed 4.75% rate. Sector-wide, U.S. hotel demand is increasingly tied to domestic leisure spending and corporate travel recovery, both of which are sensitive to consumer confidence and GDP growth.
For a deeper quantitative dive, consider exploring ValueRay’s analyst dashboards to see how HST’s valuation multiples compare to peer REITs and to model scenario-based outcomes.
HST Stock Overview
| Market Cap in USD | 12,134m |
| Sub-Industry | Hotel & Resort REITs |
| IPO / Inception | 1983-04-06 |
| Return 12m vs S&P 500 | -12.2% |
| Analyst Rating | 4.21 of 5 |
HST Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 5.19% |
| Yield on Cost 5y | 7.31% |
| Yield CAGR 5y | 45.65% |
| Payout Consistency | 66.5% |
| Payout Ratio | 85.7% |
HST Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | 2.89% |
| CAGR/Max DD Calmar Ratio | 0.08 |
| CAGR/Mean DD Pain Ratio | 0.22 |
| Current Volume | 6350.2k |
| Average Volume | 8161.7k |
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (738.0m TTM) > 0 and > 6% of Revenue (6% = 356.3m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA -1.88pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -5.46% (prev -6.40%; Δ 0.94pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.10 (>3.0%) and CFO 1.30b > Net Income 738.0m (YES >=105%, WARN >=100%) |
| Net Debt (5.10b) to EBITDA (1.79b) ratio: 2.84 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.75 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (693.9m) change vs 12m ago -1.70% (target <= -2.0% for YES) |
| Gross Margin 53.34% (prev 53.24%; Δ 0.11pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 45.47% (prev 42.65%; Δ 2.82pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.32 (EBITDA TTM 1.79b / Interest Expense TTM 234.0m) >= 6 (WARN >= 3) |
Altman Z'' 0.11
| (A) -0.02 = (Total Current Assets 991.0m - Total Current Liabilities 1.31b) / Total Assets 13.04b |
| (B) -0.04 = Retained Earnings (Balance) -563.0m / Total Assets 13.04b |
| (C) 0.08 = EBIT TTM 1.01b / Avg Total Assets 13.06b |
| (D) -0.10 = Book Value of Equity -623.0m / Total Liabilities 6.23b |
| Total Rating: 0.11 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 61.55
| 1. Piotroski 5.0pt |
| 2. FCF Yield 3.89% |
| 3. FCF Margin 11.30% |
| 4. Debt/Equity 0.85 |
| 5. Debt/Ebitda 2.84 |
| 6. ROIC - WACC (= 1.10)% |
| 7. RoE 11.12% |
| 8. Rev. Trend 53.55% |
| 9. EPS Trend -3.01% |
What is the price of HST shares?
Over the past week, the price has changed by +0.58%, over one month by +5.09%, over three months by +3.73% and over the past year by -0.55%.
Is HST a buy, sell or hold?
- Strong Buy: 10
- Buy: 3
- Hold: 6
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the HST price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 19.5 | 12.8% |
| Analysts Target Price | 19.5 | 12.8% |
| ValueRay Target Price | 18.9 | 8.9% |
HST Fundamental Data Overview November 25, 2025
P/E Trailing = 16.434
P/E Forward = 18.7266
P/S = 2.0394
P/B = 1.7985
P/EG = 2.223
Beta = 1.209
Revenue TTM = 5.94b USD
EBIT TTM = 1.01b USD
EBITDA TTM = 1.79b USD
Long Term Debt = 4.08b USD (from longTermDebt, last quarter)
Short Term Debt = 995.0m USD (from shortTermDebt, last quarter)
Debt = 5.64b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.10b USD (from netDebt column, last quarter)
Enterprise Value = 17.24b USD (12.13b + Debt 5.64b - CCE 539.0m)
Interest Coverage Ratio = 4.32 (Ebit TTM 1.01b / Interest Expense TTM 234.0m)
FCF Yield = 3.89% (FCF TTM 671.0m / Enterprise Value 17.24b)
FCF Margin = 11.30% (FCF TTM 671.0m / Revenue TTM 5.94b)
Net Margin = 12.43% (Net Income TTM 738.0m / Revenue TTM 5.94b)
Gross Margin = 53.34% ((Revenue TTM 5.94b - Cost of Revenue TTM 2.77b) / Revenue TTM)
Gross Margin QoQ = 50.79% (prev 54.41%)
Tobins Q-Ratio = 1.32 (Enterprise Value 17.24b / Total Assets 13.04b)
Interest Expense / Debt = 1.06% (Interest Expense 60.0m / Debt 5.64b)
Taxrate = 5.23% (9.00m / 172.0m)
NOPAT = 958.1m (EBIT 1.01b * (1 - 5.23%))
Current Ratio = 0.75 (Total Current Assets 991.0m / Total Current Liabilities 1.31b)
Debt / Equity = 0.85 (Debt 5.64b / totalStockholderEquity, last quarter 6.66b)
Debt / EBITDA = 2.84 (Net Debt 5.10b / EBITDA 1.79b)
Debt / FCF = 7.61 (Net Debt 5.10b / FCF TTM 671.0m)
Total Stockholder Equity = 6.64b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.66% (Net Income 738.0m / Total Assets 13.04b)
RoE = 11.12% (Net Income TTM 738.0m / Total Stockholder Equity 6.64b)
RoCE = 9.43% (EBIT 1.01b / Capital Employed (Equity 6.64b + L.T.Debt 4.08b))
RoIC = 8.17% (NOPAT 958.1m / Invested Capital 11.72b)
WACC = 7.08% (E(12.13b)/V(17.78b) * Re(9.90%) + D(5.64b)/V(17.78b) * Rd(1.06%) * (1-Tc(0.05)))
Discount Rate = 9.90% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.97%
[DCF Debug] Terminal Value 71.09% ; FCFE base≈770.2m ; Y1≈741.2m ; Y5≈728.3m
Fair Price DCF = 13.87 (DCF Value 9.54b / Shares Outstanding 687.7m; 5y FCF grow -5.06% → 3.0% )
EPS Correlation: -3.01 | EPS CAGR: 5.21% | SUE: 4.0 | # QB: 3
Revenue Correlation: 53.55 | Revenue CAGR: 1.93% | SUE: 0.98 | # QB: 1
Additional Sources for HST Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle